Optimized solution for high-resolution single-sample HLA typing using nanopore sequencing, ideal for environments requiring immediacy and flexibility.

Detailed Description

Nanotype® Mono is a compact solution from Werfen for high-resolution HLA typing based on nanopore sequencing technology (Oxford Nanopore Technologies), specially designed for the analysis of a single sample per run. It is ideal for laboratories requiring immediate results or low-volume environments, without compromising accuracy or coverage.

This product maintains the core structure of Nanotype®, based on long-range PCR and a full-read library, but is specifically optimized for individual workflows, significantly reducing preparation and analysis times. In less than 5 hours, fully assembled and assigned high-resolution haplotypes can be obtained.

Nanotype Mono Workflow

Nanotype® Mono covers the 11 clinically relevant HLA loci (HLA-A, -B, -C, -DRB1, -DRB3, -DRB4, -DRB5, -DQA1, -DQB1, -DPA1, -DPB1) and provides full-molecule sequences, preventing ambiguities and ensuring reliable, clear analysis.

The system is designed for use with ONT devices such as MinION, and employs a streamlined workflow including amplification, adapter ligation, and direct sequencer loading. Bioinformatics analysis is performed using the Nanotype® software, allowing allele assignment, manual review, visualization of covered regions, and automated reporting with clinical interpretation.

Key Features

Comprehensive single-sample HLA typing.
Fast workflow (<5 hours from DNA to result).
Optimized for MinION and individual ONT sequencers.
Long-range PCR for full coverage of the 11 HLA loci.
Unambiguously assembled haplotypes.
Integrated bioinformatics analysis with clinical interpretation.
Ideal for urgent situations or low-volume laboratories.
Nanotype Mono Data Analysis

Ordering Information

Kit name: Nanotype® Mono Contents: reagents for long-range PCR, library preparation, and data analysis Loci coverage: HLA-A, -B, -C, -DRB1, -DRB3, -DRB4, -DRB5, -DQA1, -DQB1, -DPA1, -DPB1 Technology: nanopore sequencing (Oxford Nanopore Technologies) Recommended platform: MinION Number of samples: 1 sample per run Total analysis time: <5 hours Software: Nanotype® with clinical interpretation tools

Product References

Nanotype® Mono Kit – 1 sample (RUO): Ref. NT-MONO-001 Nanotype® Mono Kit – 4 samples (RUO): Ref. NT-MONO-004 Nanotype® Mono Kit – 12 samples (RUO): Ref. NT-MONO-012 Nanotype® Software: license included in the kit (check conditions with distributor) Additional requirements (not included):
Flow Cell FLO-MIN114 (Oxford Nanopore Technologies) Rapid Barcoding Kit 24 V14 (ONT) or other compatible kit

Area:

High resolution HLA typing, Immunology, Pre transplantation

Brand:

Consult our experts

Google reCaptcha: Invalid site key.

Related products

Franklin by QIAGEN for Somatic Analysis

Advanced cloud-based bioinformatics platform designed for the automated analysis, interpretation, and classification of somatic variants in oncology. Through an integrated environment, the system evaluates clinical evidence in real time, automates classification in accordance with AMP/ASCO/CAP guidelines, and provides access to currently active clinical trials. Detailed description Operating principle End-to-end cloud-based solution for the clinical interpretation…
Qiagen
Next Generation Sequencing (NGS)

SeqOne Genomics – Somatic

SeqOne is a bioinformatics platform for NGS data analysis in precision oncology, designed to detect, prioritise and interpret somatic variants and generate actionable clinical reports from raw sequencing data. It helps laboratories and healthcare professionals accelerate the interpretation of NGS data through an end-to-end workflow. Detailed description Operating principle SeqOne Genomics is a genomic data…
SeqOne
Next Generation Sequencing (NGS)

MSK-ACCESS® powered with SOPHiA DDM™

In-house liquid biopsy solution based on hybrid-capture next-generation sequencing (NGS) technology for the ultrasensitive detection of somatic alterations in circulating cell-free DNA from plasma. Developed in collaboration with Memorial Sloan Kettering Cancer Center (MSK), it implements a robust matched tumor-normal sequencing approach (plasma cfDNA + white blood cell DNA) to filter germline variants and mutations…
SOPHIA Genetics
Next Generation Sequencing (NGS)

MSK-IMPACT® / MSK-IMPACT® FLEX

Decentralised, in-house comprehensive genomic profiling (CGP) solution for solid tumours, based on hybrid capture next-generation sequencing (NGS). Developed in collaboration with Memorial Sloan Kettering Cancer Center (MSK), it features a robust matched tumour-normal sequencing approach for filtering germline variants and clonal haematopoiesis. Detailed description Operating principle The decentralised MSK-IMPACT® powered with SOPHiA DDM™ solution enables…
SOPHIA Genetics
Next Generation Sequencing (NGS)